89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most…
42% reduction in Scope 1 and 2 Greenhouse Gas emissions by 2030 (vs. 2022)25% reduction in Scope 3 GHG emissions…
Austin, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Global Citizen Hub has formally introduced The Ultimate European Scholarship Database,…
NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until…
NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until…
New analysis of ZORYVE foam 0.3% demonstrates reduction in signs and symptoms of seborrheic dermatitis in individuals with diverse skin…
Inside Information GenSci is granted exclusive rights to ALK’s house dust mite AIT products in China. ALK will be eligible…
MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company developing OPT101 as an innovative…
SYDNEY, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Telnyx, the full-stack conversational AI platform, today announced the opening of its new…
Latest video intelligence solution transforms fleet safety by empowering drivers with instant support September 16, 2025 19:00 ET | Source:…